Clinical and genetic findings of incidental serous tubal intraepithelial carcinoma (145) by Radolec, Mackenzy, Olawaiye, Alexander, Sukumvanich, Paniti, Taylor, Sarah, Soong, T. Rinda, Mai, Phuong, Buckanovich, Ronald, Berger, Jessica, Boisen, Michelle, Coffman, Lan, Courtney-Brooks, Madeleine, Mahdi, Haider, Edwards, Robert, Lesnock, Jamie

Get full text

BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer (479) by Wield, Alyssa, Liu, Alicia, McGough, Christine, Berger, Jessica, Boisen, Michelle, Coffman, Lan, Edwards, Robert, Courtney-Brooks, Madeleine, Lesnock, Jamie, Olawaiye, Alexander, Sukumvanich, Paniti, Buckanovich, Ronald, Mahdi, Haider, Taylor, Sarah

Get full text

Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer (089) by Orellana, Taylor, Kim, Hayeon, Berger, Jessica, Bhargava, Rohit, Boisen, Michelle, Buckanovich, Ronald, Coffman, Lan, Courtney-Brooks, Madeleine, Edwards, Robert, Mahdi, Haider, Olawaiye, Alexander, Sukumvanich, Paniti, Taylor, Sarah, Smith, Kenneth, Beriwal, Sushil, Lesnock, Jamie

Get full text

The role of adjuvant treatment for early-stage uterine clear cell carcinoma (405) by Orellana, Taylor, Garrett, Alison, Soong, T. Rinda, Rives, Taylor, Courtney-Brooks, Madeleine, Taylor, Sarah, Lesnock, Jamie, Berger, Jessica, Boisen, Michelle, Coffman, Lan, Buckanovich, Ronald, Mahdi, Haider, Beriwal, Sushil, Sukumvanich, Paniti, Edwards, Robert, Bhargava, Rohit, Olawaiye, Alexander

Get full text

Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer (527) by Garrett, Alison, Wield, Alyssa, Mumford, Brigid, Janmey, Isabel, MacArthur, Emily, Edwards, Robert, Mahdi, Haider, Courtney-Brooks, Madeleine, Buckanovich, Ronald, Coffman, Lan, Olawaiye, Alexander, Sukumvanich, Paniti, Boisen, Michelle, Berger, Jessica, Taylor, Sarah, Lesnock, Jamie

Get full text

Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors by Wang, Xiangxue, Barrera, Cristian, Bera, Kaustav, Viswanathan, Vidya Sankar, Azarianpour-Esfahani, Sepideh, Koyuncu, Can, Velu, Priya, Feldman, Michael D, Yang, Michael, Fu, Pingfu, Schalper, Kurt A, Mahdi, Haider, Lu, Cheng, Velcheti, Vamsidhar, Madabhushi, Anant

Get full text

P27 BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer by Wield, Alyssa, Liu, Alicia, McGough, Christine, Berger, Jessica, Boisen, Michelle, Coffman, Lan, Edwards, Robert, Courtney-Brooks, Madeleine, Lesnock, Jamie, Olawaiye, Alexander, Sukumvanich, Paniti, Buckanovich, Ronald, Mahdi, Haider, Taylor, Sarah

Get full text

P15 Clinical outcomes following an incidental p53 signature in the fallopian tube by MacArthur, Emily, Radolec, Mackenzy, Soong, Thing Rinda, Elishaev, Esther, Sukumvanich, Paniti, Buckanovich, Ronald, Mahdi, Haider, Berger, Jessica, Taylor, Sarah, Edwards, Robert, Olawaiye, Alexander, Boisen, Michelle, Courtney-Brooks, Madeleine, Coffman, Lan, Lesnock, Jamie

Get full text

Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892) by Taylor, Sarah E., Behr, Sarah, Cooper, Kristine L., Mahdi, Haider, Fabian, Denise, Gallion, Holly, Ueland, Frederick, Vargo, John, Orr, Brian, Girda, Eugenia, Courtney-Brooks, Madeleine, Olawaiye, Alexander B., Randall, Leslie M., Richardson, Debra L., Sullivan, Stephanie A., Huang, Marilyn, Christner, Susan M., Beriwal, Sushil, Lin, Yan, Chauhan, Aman, Chu, Edward, Kohn, Elise C., Kunos, Charles, Ivy, S. Percy, Beumer, Jan H.

Get full text

Patients with recurrent gynecologic cancers and Wnt activating mutations demonstrated greater clinical benefit when treated with DKN-01 therapy by Arend, Rebecca, Castro, Cesar, Matulonis, Ursula, Hamilton, Erika, Gunderson, Camille, Lybarger, Kristopher, Goodman, Howard, Duska, Linda, Mahdi, Haider, ElNaggar, Adam, Kagey, Michael, Barroilhet, Lisa, Bradley, William, Sachdev, Jasgit, Sirard, Cynthia, O'Malley, David, Birrer, Michael

Get full text

Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition by Cascio, Sandra, Chandler, Chelsea, Zhang, Linan, Sinno, Sarah, Gao, Bingsi, Onkar, Sayali, Bruno, Tullia C, Vignali, Dario A A, Mahdi, Haider, Osmanbeyoglu, Hatice U, Vlad, Anda M, Coffman, Lan G, Buckanovich, Ronald J

Get full text

Racial disparity in the 30-day morbidity and mortality after surgery for endometrial cancer by Mahdi, Haider, Lockhart, David, Moslemi-Kebria, Mehdi, Rose, Peter G

Get full text

Type II endometrial cancer in Hispanic women: Tumor characteristics, treatment and survival compared to non-Hispanic white women by Mahdi, Haider, Hou, Huiying, Kowk, Li-Lian, Moslemi-Kebria, Mehdi, Michener, Chad

Get full text

Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma by Mahdi, Haider, Xiu, Joanne, Reddy, Sandeep K., DeBernardo, Robert

Get full text

Ni, Cu, and Zn metal ions removal from synthetic wastewater using a watermelon rind (Catullus landaus) by Shakor, Zaidoon M., Mahdi, Haider H., Al-Sheikh, Farooq, Alwan, Ghanim M., Al-Jadir, Thaer

Get full text

FOXL2 mutation is prevalent in metastatic adult granulosa cell tumors and is associated with improved survival by MacArthur, Emily, Garrett, Alison, Wu, Sharon, Xiu, Joanne, Brown, Jubilee, Holloway, Robert, Herzog, Thomas, Thaker, Premal, Korn, Michael, Courtney-Brooks, Madeleine, Sukumvanich, Paniti, Buckanovich, Ronald, Edwards, Robert, Mahdi, Haider, Taylor, Sarah, Berger, Jessica, Olawaiye, Alexander, Boisen, Michelle, Coffman, Lan, Jones, Nathaniel, Lesnock, Jamie

Get full text

Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study by Elshaikh, Mohamed A, Al-Wahab, Zaid, Mahdi, Haider, Albuquerque, Kevin, Mahan, Meredith, Kehoe, Siobhan M, Ali-Fehmi, Rouba, Rose, Peter G, Munkarah, Adnan R

Get full text

Abstract A080: Olaparib and the ATR inhibitor AZD6738 in relapsed, refractory cancer patients with homologous recombination (HR) repair mutations – OLAPCO by Eder, Joseph Paul, Sohal, Davendra, Mahdi, Haider, Do, Khanh, Keedy, Vicki, Hafez, Navid, Doroshow, Deborah, Avedissian, Manuel, Mortimer, Peter, Glover, Colin, LoRusso, Patricia, Juergensmeier, Juliane M, Shapiro, Geoffrey I

Get full text

Enhancement of corrosion resistance and mechanical properties of API 5L X60 steel by heat treatments in different environments by Jasim, Rad Jamal, Layth, Haydar Mahdi, al-Sabur, Rahim Kh, al-Sahlani, Ahmad

Get full text

Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study by Mahdi, Haider, Elshaikh, Mohamed A, DeBenardo, Robert, Munkarah, Adnan, Isrow, Derek, Singh, Sareena, Waggoner, Steven, Ali-Fehmi, Rouba, Morris, Robort T, Harding, Jarod, Moslemi-Kebria, Mehdi

Get full text